CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
A phase I first-in-human study of ARGX-110, a monoclonal antibody targeting CD70, a receptor involved in immune escape and tumor growth in patients with solid and hematologic malignancies
Authors
Philippe G Aftimos
Ahmad Awada
+12Â more
Dominique Bron
Hans de Heard
Laure Ysebrant de Lendonck
Torsten Dreier
Mahan Moshir
Fritz Offner
Marc Posters
Christian D Rolfo
Sylvia Rottey
Wilfrled A Schroyens
Karen Silence
Alain Thibault
Publication date
1 January 2014
Publisher
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Ghent University Academic Bibliography
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:archive.ugent.be:7004678
Last time updated on 12/11/2016